MSK
Morgan Stanley Capital Trust VIII
DELISTED - Morgan Stanley Capital Trust VIII (the Trust) is a trust that exists solely to issue and sell its common securities to Morgan Stanley, and issues and sells its capital securities to the public. The Trust uses the proceeds from the sale of its common securities and capital securities to purchase junior subordinated debentures from Morgan Stanley, and engages in other activities that are necessary or incidental to these purposes. The Trust holds directly or indirectly all of the common securities of each of the Morgan Stanley Capital Trusts. The junior subordinated debentures will be the Trust's only assets.
Current Price
$25.76
GoodMoat Value
$6.65
74.2% overvaluedMorgan Stanley Capital Trust VIII (MSK) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Morgan Stanley Capital Trust VIII's financial performance and position as a Consumer Defensive company.
Trailing twelve-month (TTM) revenue is $518.53M. Gross profit (TTM) is $136.46M. EBITDA is $58.43M. Earnings per share (EPS) is $0.59.
Free cash flow (FCF) is $45.39M. FCF growth rate is -13.15%. EPS growth CAGR is -3.45%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 5 years from FY00 to FY04. Net income history spans 5 years. Free cash flow and capital expenditure data spans 5 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Morgan Stanley Capital Trust VIII's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
